CLSD - クリアサイド・バイオメディカル (Clearside Biomedical Inc.)

CLSDのニュース

   Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q1 2019 Results - Earnings Call Transcript  2019-05-08
Clearside Biomedical, Inc. (CLSD) Q1 2019 Earnings Conference Call May 08, 2019, 08:30 AM ET Company Participants Jenny Kobin - IR George Lasezkay - Interim CEO Thomas Ciulla - Chief Medical Officer Brion Raymond - Chief Commercial Officer Charlie Deignan - CFO Conference …
   Clearside Biomedical beats by $0.02  2019-05-08
Clearside Biomedical (NASDAQ: CLSD ): Q1 GAAP EPS of -$0.45 beats by $0.02. More news on: Clearside Biomedical, Inc., Earnings news and commentary, Healthcare stocks news, , Read more …

calendar